Trial intelligence / Profile preview

Baclofen Effects on Smoking Urge and Withdrawal

NCT00257894Phase 2Terminated

Sponsor
VA Office of Research & Development
Start
Dec 2005
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Tobacco Use Disorder (TUD) comparing Baclofen with Placebo (2 arms). Primary endpoints: Questionnaire of Smoking Urges at Day 10 and Minnesota Nicotine Withdrawal Questionnaire at Day 10. Started Dec 2005; status: terminated.

02

Drugs

baclofen
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00257894.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00257894.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call